Search Within

Saad Zafar Usmani

Formats
  1. Meeting Abstract (223)
  2. Journal Article (82)
  3. Review (16)
  4. Research Letter (11)
  5. Correspondence (5)
  6. Editorial (4)
  7. Guidelines (3)
  8. Book Section (1)
Groups
  1. Hematologic Malignancies, Division of (171)
  2. Department of Medicine (168)
  3. Center for Hematologic Malignancies (161)
  4. Graduate Medical Education (151)
  5. Myeloma (149)
  6. GME, Medicine (142)

More Groups

People
  1. Alexander Lesokhin (129)
  2. Kylee Maclachlan (127)
  3. Sham Mailankody (113)
  4. Urvi Shah (110)
  5. Carlyn Rose Tan (105)
  6. Neha Korde (103)

More People

Years
  1. 2025 (42)
  2. 2024 (97)
  3. 2023 (123)
  4. 2022 (83)
Publications
  1. Blood (110)
  2. Clinical Lymphoma, Myeloma and Leukemia (81)
  3. Journal of Clinical Oncology (32)
  4. Blood Cancer Journal (16)
  5. Blood Advances (15)
  6. British Journal of Haematology (8)

More Publications

Publishers
  1. American Society of Hematology (125)
  2. Elsevier Inc. (94)
  3. American Society of Clinical Oncology (32)
  4. Nature Publishing Group (24)
  5. Elsevier Science, Inc. (10)
  6. John Wiley & Sons (9)

More Publishers

Results (345)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Failure patterns by PET for relapsed / refractory Multiple Myeloma (r/r MM) after CART cell therapy: Potential role for radiotherapy (RT)?
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Hubbeling, H. G.; Mailankody, S.; Usmani, S.; Yahalom, J.; Imber, B. S.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Radiation therapy (RT) in a new era of Multiple Myeloma (MM) therapy: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Cederquist, G.; Usmani, S.; Imber, B. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders
    Editorial

    Usmani, S. Z.; Ghosh, N.; Voorhees, P.; Copelan, E.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Daratumumab + bortezomib/lenalidomide/dexamethasone in patients with transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: Results of the phase 3 CEPHEUS study
    Meeting Abstract

    Usmani, S. Z.; Facon, T.; Hungria, V.; Bahlis, N. J.; Venner, C. P.; Braunstein, M.; Pour, L.; Marti, J.; Basu, S.; Cohen, Y. C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Evaluation of the safety and efficacy of denosumab in patients with multiple myeloma and severe renal impairment
    Meeting Abstract

    Terpos, E.; Ntanasis-Stathopoulos, I.; Kyriakou, C.; Tan, C.; Abildgaard, N.; Delforge, M.; Fantl, D.; Usmani, S.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Incidence, timing, and management of infections in patients receiving daratumumab for the treatment of newly diagnosed transplant-ineligible multiple myeloma in the MAIA study
    Meeting Abstract

    Bahlis, N. J.; Facon, T.; Usmani, S.; Moreau, P.; Raje, N.; Zweegman, S.; Chari, A.; Perrot, A.; Manier, S.; Orlowski, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-eligible patients with multiple myeloma: A pooled analysis of patients aged ≥65 years from both PERSEUS and GRIFFIN studies
    Meeting Abstract

    Rodríguez-Otero, P.; Voorhees, P. M.; Boccadoro, M.; Laubach, J.; Einsele, H.; Sborov, D. W.; Dimopoulos, M.; Broijl, A.; Mina, R.; Spencer, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with Talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Clonal evolution of multiple myeloma following the mutagenic impact of radiotherapy
    Meeting Abstract

    Diamond, B.; Chahar, D.; Jain, M.; Poos, A.; Durante, M.; Ziccheddu, B.; Maclachlan, K.; Davies, F.; Figura, N.; Morgan, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K.; Papadimitriou, M.; Blaney, P.; McPherson, A.; Chu, T.; Diamond, B.; Ziccheddu, B.; Shekarkhand, T.; Poos, A.; Brown, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save